Laura Tosi, MD
Pediatric Orthopaedic Surgery · Washington, DCNPI 1801986278
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,225 of the $5,626 with a category attached, or 75.1%. Biomarin Pharmaceutical Inc. accounts for 78.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $4,741 and has fallen 88.3% since, to $555 in 2025.
Across 18 payments — averaging $312.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$4K
- Kyowa Kirin, Inc.$361
- Integra Lifesciences Corporation$245
- Amgen$209
- AstraZeneca$160
- Radius Health, Inc.$102
- plus $132 from 2 others
Across 132 payments — averaging $6367.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$841K
What the payments were for
- Speaking & faculty fees$4,22575%
- Food & beverage$1,12520%
- Education$311%
- Other$2454%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 3 | $4,416 |
| Kyowa Kirin, Inc. | 5 | $361 |
| Integra Lifesciences Corporation | 1 | $245 |
| Amgen | 2 | $209 |
| AstraZeneca | 2 | $160 |
| Radius Health, Inc. | 1 | $102 |
| Orthopediatrics Corp. | 1 | $77 |
| Smith+Nephew | 3 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$4,225
- ACell$245
- CRYSVITA$227
- Strensiq$129
- Tymlos$102
How this compares
Too few pediatric orthopaedic surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric orthopaedic surgery in Washington
- Matthew OetgenWashington$23K
- Megan YoungWashington$10K
- Jimmy DaherWashington$3K
- Sanoj ShahulWashington$2K
- Shannon KellyWashington$879
- L FriendWashington$162
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.